Actinium Pharmaceuticals SG&A Expense (Quarterly) Analysis

Actinium Pharmaceuticals Inc (ATNM)

8.96 +0.21 (+2.40%) USD | NYAM | May 03, 16:00

8.915 -0.04 (-0.50%) After-Hours: 20:00

SG&A Expense (Quarterly) Chart

Historical SG&A Expense (Quarterly) Data

View and export this data back to 2006. Upgrade now.

Date	Value
March 31, 2024	2.962M
December 31, 2023	2.306M
September 30, 2023	2.729M
June 30, 2023	4.561M
March 31, 2023	3.735M
December 31, 2022	3.958M
September 30, 2022	3.073M
June 30, 2022	3.233M
March 31, 2022	1.735M
December 31, 2021	2.655M
September 30, 2021	1.994M
June 30, 2021	1.71M
March 31, 2021	1.718M
December 31, 2020	1.796M
September 30, 2020	1.825M
June 30, 2020	1.154M
March 31, 2020	1.532M
December 31, 2019	1.26M
September 30, 2019	1.822M
June 30, 2019	1.076M
March 31, 2019	1.363M
December 31, 2018	1.292M
September 30, 2018	1.970M
June 30, 2018	1.583M
March 31, 2018	1.887M

Date	Value
December 31, 2017	1.582M
September 30, 2017	1.657M
June 30, 2017	2.741M
March 31, 2017	3.211M
December 31, 2016	2.655M
September 30, 2016	1.395M
June 30, 2016	2.750M
March 31, 2016	2.218M
December 31, 2015	2.123M
September 30, 2015	1.795M
June 30, 2015	3.550M
March 31, 2015	3.806M
December 31, 2014	2.453M
September 30, 2014	2.889M
June 30, 2014	2.286M
March 31, 2014	2.547M
December 31, 2013	0.7466M
September 30, 2013	0.8307M
June 30, 2013	0.9664M
March 31, 2013	0.9331M
December 31, 2012	2.986M
September 30, 2012	0.722M
June 30, 2012	0.2379M
March 31, 2012	0.5603M
December 31, 2011	2.951M

SG&A Expense Definition

SG&A expense (short for Selling, General and Administrative expense) is a line item on the income statement, though sometimes sales and marketing expenses are reported separately from general and administrative expenses.

Read full definition.

SG&A Expense (Quarterly) Range, Past 5 Years

1.076M

Minimum

Jun 2019

4.561M

Maximum

Jun 2023

2.342M

Average

1.910M

Median

SG&A Expense (Quarterly) Benchmarks